Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00942227 · ClinicalTrials.gov registry record · Phase 3

The Value of Traction in Treatment of Lumbar Radiculopathy

A Phase 3 study, sponsored by Intermountain Health Care.

Completed
Registry status
Phase 3
Development phase
120
Enrollment target

NCT00942227: Completed Phase 3 study, sponsored by Intermountain Health Care.

NCT00942227 is a Phase 3 study that has completed, run by Intermountain Health Care. The registered enrollment target is 120 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (84% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00942227, a Phase 3 study, has completed, sponsored by Intermountain Health Care.

COMPLETED
Registry status
Phase 3
Development phase
120 participants
Enrollment target

Study Summary

The purpose of this study is to determine the effectiveness of adding mechanical traction to standard physical therapy treatments for patients with low back pain.

Interventions

  • OTHER Physical therapy rehabilitation

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2009-07
Est. Completion 2012-12
Phase Phase 3
Intermountain Health Care

85 total trials

What the finished NCT00942227 record still lists

NCT00942227 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (84% lower).

The record links to 0 conditions, and to 1 intervention - of which Physical therapy rehabilitation is the first listed.

NCT00942227 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00942227 about?

NCT00942227 is a clinical study titled "The Value of Traction in Treatment of Lumbar Radiculopathy". The purpose of this study is to determine the effectiveness of adding mechanical traction to standard physical therapy treatments for patients with low back pain.

What is the current status of trial NCT00942227?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 120 participants. The study started on 2009-07. Estimated completion is 2012-12.

What interventions are being tested in trial NCT00942227?

The interventions under investigation include: Physical therapy rehabilitation (OTHER).

Who is sponsoring clinical trial NCT00942227?

This trial is sponsored by Intermountain Health Care, which has 85 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00942227's enrollment target sits among peer trials

120 1619th of 2000 higher than 361 of 2,000 other Phase 3 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01174108 · 120 participants · Phase 2

    Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells

  • NCT01627301 · 120 participants · NA

    Sympathetic Overactivity in Post-traumatic Stress Disorder

  • NCT02025023 · 120 participants · Phase 3

    Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study

  • NCT02128906 · 120 participants · Phase 2

    Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00942227, the US trial registry maintained by the National Library of Medicine. NCT00942227 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.